Market Overview

Benzinga's Top Upgrades, Downgrades For March 18, 2020

Share:

Upgrades

  • Morgan Stanley changed the rating for Paychex Inc (NASDAQ: PAYX) from Underweight to Equal-Weight. Paychex earned $0.70 in the second quarter, compared to $0.65 in the year-ago quarter. The stock has a 52-week-high of $90.53 and a 52-week-low of $54.48. Paychex's stock last closed at $60.79 per share.
  • BTIG changed the rating for Globus Medical Inc (NYSE: GMED) from Neutral to Buy. In the fourth quarter, Globus Medical showed an EPS of $0.49, compared to $0.43 from the year-ago quarter. The stock has a 52-week-high of $60.15 and a 52-week-low of $33.41. Globus Medical's stock last closed at $39.97 per share.
  • Susquehanna changed the rating for MGM Resorts International (NYSE: MGM) from Negative to Neutral. In the fourth quarter, MGM Resorts Intl earned $0.08. The stock has a 52-week-high of $34.63 and a 52-week-low of $9.00. MGM Resorts Intl's stock last closed at $9.54 per share.
  • B of A Securities changed the rating for Central Garden & Pet Co (NASDAQ: CENT) from Neutral to Buy. In the first quarter, Central Garden & Pet showed an EPS of ($0.08), compared to $0.03 from the year-ago quarter. The stock has a 52-week-high of $34.69 and a 52-week-low of $22.40. Central Garden & Pet's stock last closed at $29.65 per share.
  • For The Hershey Co (NYSE: HSY), Credit Suisse upgraded the stock from Neutral to Outperform. For the fourth quarter, Hershey had an EPS of $1.28, compared to year-ago quarter EPS of $1.26. The stock has a 52-week-high of $162.20 and a 52-week-low of $108.95. Hershey's stock last closed at $138.94 per share.
  • UBS changed the rating for Caterpillar Inc (NYSE: CAT) from Sell to Neutral. For the fourth quarter, Caterpillar had an EPS of $2.63, compared to year-ago quarter EPS of $2.55. The stock has a 52-week-high of $150.55 and a 52-week-low of $87.50. Caterpillar's stock last closed at $100.20 per share.
  • Dougherty & Co. changed the rating for NextGen Healthcare Inc (NASDAQ: NXGN) from Neutral to Buy. In the third quarter, NextGen Healthcare showed an EPS of $0.23, compared to $0.20 from the year-ago quarter. The stock has a 52-week-high of $21.12 and a 52-week-low of $5.10. NextGen Healthcare's stock last closed at $6.15 per share.
  • For Change Healthcare Inc (NASDAQ: CHNG), Raymond James upgraded the stock from Outperform to Strong Buy. Interestingly, in the third quarter, Change Healthcare's EPS was $0.33. The stock has a 52-week-high of $17.57 and a 52-week-low of $6.67. Change Healthcare's stock last closed at $7.78 per share.

 

Downgrades

  • Morgan Stanley changed the rating for Monster Beverage Corp (NASDAQ: MNST) from Overweight to Equal-Weight. For the fourth quarter, Monster Beverage had an EPS of $0.47, compared to year-ago quarter EPS of $0.43. The stock has a 52-week-high of $70.52 and a 52-week-low of $52.23. Monster Beverage's stock last closed at $59.74 per share.
  • B. Riley FBR downgraded the stock for Sinclair Broadcast Group Inc (NASDAQ: SBGI) from Buy to Neutral. Sinclair Broadcast Group earned $0.94 in the fourth quarter, compared to $2.13 in the year-ago quarter. The stock has a 52-week-high of $66.57 and a 52-week-low of $10.94. Sinclair Broadcast Group's stock last closed at $13.54 per share.
 

Related Articles (CENT + CAT)

View Comments and Join the Discussion!

Posted-In: Initiations top upgradesUpgrades Downgrades Initiation Intraday Update Analyst Ratings

Latest Ratings

StockFirmActionPT
PECFRAMaintains8.0
HUNCFRAUpgrades16.0
CCCFRADowngrades11.0
VOYAPiper SandlerMaintains58.0
PRUPiper SandlerMaintains64.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com